ECI Biotech

About:

ECI Biotech is a premier developer and manufacturer of innovative, patented ExpressDetect a sensors for rapid infection.

Website: http://www.ecibiotech.com

Twitter/X: ECIBiotech

Top Investors: National Institutes of Health, MassDevelopment

Description:

ECI is developing and licensing its protein technologies for use in a wide range of industries with unmet needs, including nosocomial infections, medical diagnostics, industrial chemistry and consumer goods. ECI Biotech's product pipeline currently includes a diagnostic sensor for urinary tract infections, as well as advanced wound care systems designed to provide early warning of emergent infections and to promote healing. ECI presently also has 2 corporate partnerships with Fortune 100 companies in the medical device industry.

Total Funding Amount:

$3.4M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Worcester, Massachusetts, United States

Founded Date:

1998-01-01

Contact Email:

info(AT)ecibiotech.com

Founders:

Mitchell Sanders

Number of Employees:

1-10

Last Funding Date:

2010-01-26

IPO Status:

Private

Industries:

© 2025 bioDAO.ai